Creso Pharma Ltd
ASX:CPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iktinos Hellas Greek Marble Industry SA
ATHEX:IKTIN
|
GR |
|
C
|
Champion Electric Metals Inc
CNSX:LTHM
|
CA |
|
Proya Cosmetics Co Ltd
SSE:603605
|
CN |
Creso Pharma Ltd
Total Current Liabilities
Creso Pharma Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Creso Pharma Ltd
ASX:CPH
|
Total Current Liabilities
AU$15.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Total Current Liabilities
AU$11.4m
|
CAGR 3-Years
114%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Total Current Liabilities
AU$261m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Total Current Liabilities
AU$4.3m
|
CAGR 3-Years
37%
|
CAGR 5-Years
42%
|
CAGR 10-Years
6%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Total Current Liabilities
AU$10.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Total Current Liabilities
AU$545.6k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Creso Pharma Ltd
Glance View
Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.
See Also
What is Creso Pharma Ltd's Total Current Liabilities?
Total Current Liabilities
15.7m
AUD
Based on the financial report for Dec 31, 2022, Creso Pharma Ltd's Total Current Liabilities amounts to 15.7m AUD.
What is Creso Pharma Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 1Y
909%
Over the last year, the Total Current Liabilities growth was 909%.
